Brief: Kenneth Griffin Reports 5.4% Passive Stake In Zentalis Pharmaceuticals As Of Nov 7 - SEC Filing
Nov 17 (Reuters) - Zentalis Pharmaceuticals Inc
ZNTL.O :
* KENNETH GRIFFIN REPORTS 5.4% PASSIVE STAKE IN ZENTALIS
PHARMACEUTICALS INC AS OF NOV 7 - SEC FILING
Further company coverage: ZNTL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer